IMPROVING GLOBAL HEALTH THROUGH OUR ADVANCED ORAL INSULIN TECHNOLOGY
Needles are Need-less!
What We Do
Oral Insulin for Adults and Pediatrics
Lipid Nano Particle Development and Testing
Lipid Nano Particle Development and Testing
Our groundbreaking oral insulin program aims to eliminate needles for diabetics worldwide using an innovative soft chew delivery system as a first in class treatment for Type One (Juvenile) diabetes.
Galileo Biologics pioneers programmable nano-particles for precise drug delivery for the diabetic patient population.
Lipid Nano Particle Development and Testing
Lipid Nano Particle Development and Testing
Lipid Nano Particle Development and Testing
Advancing Next-Generation Treatments for the Growing Global Diabetes Epidemic and Other Globally Neglected Diseases through the application of Next-Generation Thermally Stable Payloads for All Climates.
Pharmaceutical Manufacturing & Trade Secrets
Lipid Nano Particle Development and Testing
Pharmaceutical Manufacturing & Trade Secrets
Galileo has numerous trade secrets which protect the development of liposomal nanocapsules.
Our technology not only protects insulin from degradation in the stomach but also enables optimal absorption in the intestinal tract and precise targeted delivery, opening new horizons for diabetes treatment.